Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
60 studies found for:    "Dermatomyositis"
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Conditions: Dermatomyositis;   Juvenile Dermatomyositis
Intervention: Drug: H.P. Acthar Gel
2 Recruiting Abatacept in Juvenile Dermatomyositis
Condition: Dermatomyositis
Intervention: Drug: Abatacept
3 Completed
Has Results
A Pilot Study of Etanercept in Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: Etanercept;   Drug: Placebo
4 Completed Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)
Conditions: Polymyositis;   Dermatomyositis
Interventions: Drug: GB-0998;   Drug: Placebo of GB-0998
5 Completed Methimazole to Treat Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: methimazole
6 Recruiting Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Interventions: Drug: tocilizumab;   Drug: placebo
7 Recruiting Trial of IMO-8400 in Adult Patients With Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: IMO-8400 Dose Group 1;   Drug: IMO-8400 Dose Group 2;   Drug: Placebo
8 Completed Hand Function in Patients With Poly- or Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention:
9 Completed Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis
Condition: Dermatomyositis
Intervention: Drug: h5G1.1-mAb
10 Completed Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Infliximab
11 Active, not recruiting Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Adrenocorticotropic Hormone Gel
12 Completed Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention: Drug: Immunosuppressive Agents
13 Terminated Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: Prednisone;   Drug: Methotrexate;   Drug: Etanercept
14 Completed
Has Results
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Conditions: Myositis;   Dermatomyositis;   Polymyositis;   Juvenile Dermatomyositis
Interventions: Drug: Rituximab;   Drug: Placebo
15 Completed Safety and Efficacy of BAF312 in Dermatomyositis
Condition: Active Dermatomyositis
Interventions: Drug: BAF312 0.5 mg;   Drug: BAF312 2 mg;   Drug: BAF312 10 mg;   Drug: Placebo to BAF312
16 Unknown  Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
Condition: Juvenile Dermatomyositis
Interventions: Drug: 3 MPDN pulse + PDN;   Drug: 3 MPDN pulse + PDN + CSA;   Drug: 3 MPDN pulse + PDN + MTX
17 Enrolling by invitation Dermatomyositis and Polymyositis Registry
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Acthar
18 Unknown  Abatacept Treatment in Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention: Drug: Abatacept
19 Completed Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy
Conditions: Polymyositis;   Dermatomyositis
Intervention: Other: Patients with polymyositis / dermatomyositis
20 Completed Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Other: Active rehabilitation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years